Logo image of CHG.DE

CHAPTERS GROUP AG (CHG.DE) Stock Fundamental Analysis

FRA:CHG - Deutsche Boerse Ag - DE0006618309 - Common Stock - Currency: EUR

32  0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CHG. CHG was compared to 47 industry peers in the Financial Services industry. Both the profitability and financial health of CHG have multiple concerns. CHG is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CHG had negative earnings in the past year.
CHG had a positive operating cash flow in the past year.
In multiple years CHG reported negative net income over the last 5 years.
In the past 5 years CHG reported 4 times negative operating cash flow.
CHG.DE Yearly Net Income VS EBIT VS OCF VS FCFCHG.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

1.2 Ratios

CHG has a worse Return On Assets (-3.10%) than 80.85% of its industry peers.
CHG has a Return On Equity of -5.54%. This is in the lower half of the industry: CHG underperforms 78.72% of its industry peers.
Industry RankSector Rank
ROA -3.1%
ROE -5.54%
ROIC N/A
ROA(3y)-1.36%
ROA(5y)-9.09%
ROE(3y)-1.95%
ROE(5y)-11.98%
ROIC(3y)N/A
ROIC(5y)N/A
CHG.DE Yearly ROA, ROE, ROICCHG.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

1.3 Margins

The Gross Margin of CHG (80.66%) is better than 78.72% of its industry peers.
In the last couple of years the Gross Margin of CHG has declined.
CHG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 80.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-5.44%
CHG.DE Yearly Profit, Operating, Gross MarginsCHG.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20K -20K 40K -40K 60K

More info and screens

3

2. Health

2.1 Basic Checks

CHG does not have a ROIC to compare to the WACC, probably because it is not profitable.
CHG has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CHG has been increased compared to 5 years ago.
The debt/assets ratio for CHG is higher compared to a year ago.
CHG.DE Yearly Shares OutstandingCHG.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
CHG.DE Yearly Total Debt VS Total AssetsCHG.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

CHG has an Altman-Z score of 3.82. This indicates that CHG is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CHG (3.82) is better than 72.34% of its industry peers.
The Debt to FCF ratio of CHG is 6.46, which is on the high side as it means it would take CHG, 6.46 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 6.46, CHG perfoms like the industry average, outperforming 59.57% of the companies in the same industry.
CHG has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.17, CHG is doing good in the industry, outperforming 74.47% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 6.46
Altman-Z 3.82
ROIC/WACCN/A
WACC7.16%
CHG.DE Yearly LT Debt VS Equity VS FCFCHG.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.3 Liquidity

CHG has a Current Ratio of 0.70. This is a bad value and indicates that CHG is not financially healthy enough and could expect problems in meeting its short term obligations.
CHG's Current ratio of 0.70 is on the low side compared to the rest of the industry. CHG is outperformed by 68.09% of its industry peers.
A Quick Ratio of 0.65 indicates that CHG may have some problems paying its short term obligations.
With a Quick ratio value of 0.65, CHG is not doing good in the industry: 70.21% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.65
CHG.DE Yearly Current Assets VS Current LiabilitesCHG.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.70% over the past year.
The Revenue has grown by 158.74% in the past year. This is a very strong growth!
CHG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 93.11% yearly.
EPS 1Y (TTM)4.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.88%
Revenue 1Y (TTM)158.74%
Revenue growth 3Y303.43%
Revenue growth 5Y93.11%
Sales Q2Q%48.63%

3.2 Future

CHG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 416.76% yearly.
Based on estimates for the next years, CHG will show a very strong growth in Revenue. The Revenue will grow by 32.75% on average per year.
EPS Next Y3700%
EPS Next 2Y794.43%
EPS Next 3Y416.77%
EPS Next 5YN/A
Revenue Next Year56.5%
Revenue Next 2Y42.64%
Revenue Next 3Y32.75%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CHG.DE Yearly Revenue VS EstimatesCHG.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
CHG.DE Yearly EPS VS EstimatesCHG.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 0.2 0.4 0.6 0.8 1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CHG. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 40.62, the valuation of CHG can be described as expensive.
Based on the Price/Forward Earnings ratio, CHG is valued a bit more expensive than 70.21% of the companies in the same industry.
CHG's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.86.
Industry RankSector Rank
PE N/A
Fwd PE 40.62
CHG.DE Price Earnings VS Forward Price EarningsCHG.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHG is valued a bit more expensive than the industry average as 63.83% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, CHG is valued a bit more expensive than the industry average as 61.70% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 66.55
EV/EBITDA 94.7
CHG.DE Per share dataCHG.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CHG's earnings are expected to grow with 416.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y794.43%
EPS Next 3Y416.77%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CHG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHAPTERS GROUP AG

FRA:CHG (5/2/2025, 7:00:00 PM)

32

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)N/A N/A
Earnings (Next)05-22 2025-05-22
Inst Owners8.85%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap735.68M
Analysts80
Price Target36.72 (14.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.88%
PT rev (3m)28.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 40.62
P/S 8.44
P/FCF 66.55
P/OCF 47.47
P/B 5.03
P/tB 74.32
EV/EBITDA 94.7
EPS(TTM)-0.41
EYN/A
EPS(NY)0.79
Fwd EY2.46%
FCF(TTM)0.48
FCFY1.5%
OCF(TTM)0.67
OCFY2.11%
SpS3.79
BVpS6.37
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.1%
ROE -5.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 80.66%
FCFM 12.69%
ROA(3y)-1.36%
ROA(5y)-9.09%
ROE(3y)-1.95%
ROE(5y)-11.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-5.44%
F-Score7
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 6.46
Debt/EBITDA 3.18
Cap/Depr 28.42%
Cap/Sales 5.1%
Interest Coverage N/A
Cash Conversion 197.34%
Profit Quality N/A
Current Ratio 0.7
Quick Ratio 0.65
Altman-Z 3.82
F-Score7
WACC7.16%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.88%
EPS Next Y3700%
EPS Next 2Y794.43%
EPS Next 3Y416.77%
EPS Next 5YN/A
Revenue 1Y (TTM)158.74%
Revenue growth 3Y303.43%
Revenue growth 5Y93.11%
Sales Q2Q%48.63%
Revenue Next Year56.5%
Revenue Next 2Y42.64%
Revenue Next 3Y32.75%
Revenue Next 5YN/A
EBIT growth 1Y-599.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8233.33%
EBIT Next 3Y451.79%
EBIT Next 5Y194.3%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A